Monoclonal and bispecific antibodies as novel therapeutics (original) (raw)

Profile image of Sherif LouisSherif Louis

2006, Archivum Immunologiae et Therapiae Experimentalis

visibility

description

18 pages

link

1 file

Sign up for access to the world's latest research.

checkGet notified about relevant papers

checkSave papers to use in your research

checkJoin the discussion with peers

checkTrack your impact

Monoclonal antibodies: Pharmacological relevance

Prem Khosla

Indian Journal of Pharmacology, 2007

View PDFchevron_right

MURINE AND HUMANIZED MONOCLONAL ANTIBODIES AND THEIR THERAPEUTIC APPLICATIONS. Review Article

Taha Nazir

View PDFchevron_right

Therapeutic antibodies for human diseases at the dawn of the twenty-first century

Inger Sandlie

Nature Reviews Drug Discovery, 2003

View PDFchevron_right

Engineering antibodies for clinical applications

NEEL KAMAL

Trends in Biotechnology, 2007

View PDFchevron_right

Chemically Programmed Bispecific Antibodies That Recruit and Activate T Cells

Joshua Thomas

Journal of Biological Chemistry, 2012

View PDFchevron_right

Therapeutic Human ANTI-IL-1R1 Monoclonal Antibody

Haichun Huang

View PDFchevron_right

Monoclonal antibodies for cancer: a focus on mechanisms of action

Hardik Gandhi

Journal of Integrated Health Sciences, 2013

View PDFchevron_right

Antibody Therapy: From Diphtheria to Cancer, COVID-19, and Beyond

Nagendra R Hegde

Monoclonal antibodies in immunodiagnosis and immunotherapy, 2021

View PDFchevron_right

Approaches to improve tumor accumulation and interactions between monoclonal antibodies and immune cells

A. Corti

mAbs, 2013

View PDFchevron_right

Pre-existing Antibody: Biotherapeutic Modality-Based Review

Boris Gorovits

The AAPS Journal, 2016

View PDFchevron_right

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

Biosimilar monoclonal antibodies—challenges and opportunities in Europe

Andrea Laslop

Generics and Biosimilars Initiative Journal, 2013

View PDFchevron_right

Development and Application of Single Chain Antibodies for PD Therapy

Howard Federoff

2004

View PDFchevron_right

Multiformat T-Cell-Engaging Bispecific Antibodies Targeting Human Breast Cancers

Shailaja Srinagesh

Angewandte Chemie, 2015

View PDFchevron_right

In vivo clearing of idiotypic antibodies with antiidiotypic antibodies and their derivatives

Birgitta Sundström

Molecular Immunology, 2006

View PDFchevron_right

Treatment of autoimmune disease with monoclonal anti-CD4 antibodies

Matthew Waldor

Immunology series, 1989

View PDFchevron_right

Specific killing of human melanoma cells by 125I-labeled 9.2.27 monoclonal antibody

George Morstyn

Cancer Research, 1985

View PDFchevron_right

Emerging Monoclonal Antibody Therapy for the Treatment of Acute Lymphoblastic Leukemia

Ariella Tvito

Biologics: Targets and Therapy, 2021

View PDFchevron_right

The use of bispecific antibodies in tumor cell and tumor vasculature directed immunotherapy

Wijnand Helfrich

Journal of Controlled Release, 2000

View PDFchevron_right

Peptides, mAbs, bispecifics, oh my! clinical pharmacology challenges in the development of biologics

Joan Korth-Bradley

Journal of clinical pharmacology, 2015

View PDFchevron_right

Development of 203Pb as a new label for monoclonal antibodies

Ronnie Mease

Journal of Labelled Compounds and Radiopharmaceuticals, 1989

View PDFchevron_right

The Advantage of Antibody Cocktails for Targeted Alpha Therapy Depends on Specific Activity

Jason Domogauer

The Journal of Nuclear Medicine, 2014

View PDFchevron_right

A monoclonal antibody to human B lymphoblastoid cells activates human and murine T lymphocytes

Britta Hardy

Cellular Immunology, 1989

View PDFchevron_right

Simple method for selecting catalytic monoclonal antibodies that exhibit turnover and specificity

Rina Arad-Yellin

Biochemistry, 1990

View PDFchevron_right

The Irony of Humanization: Alemtuzumab, the First, But One of the Most Immunogenic, Humanized Monoclonal Antibodies

Angray Kang

Frontiers in Immunology, 2020

View PDFchevron_right

Antibodies Applications and New Developments

David Hage

2012

View PDFchevron_right

Immunodetection of human tumour-associated cell-bound antigens by human monoclonal antibodies

Agnieszka Czopik

Journal of Immunological Methods, 1989

View PDFchevron_right

The European antibody network's practical guide to finding and validating suitable antibodies for research

Vanda Lisnic

mAbs, 2015

View PDFchevron_right

Bispecific Antibodies in Hematological Malignancies: A Scoping Review

Ahmed Yaqinuddin

Cancers, 2023

View PDFchevron_right

A multivalent recombinant antibody fragment specific for carcinoembryonic antigen

Monica Bequet

Biotechnology and Applied Biochemistry, 2006

View PDFchevron_right

Immunotherapy/Biological Therapies

iwan sumantri

Neuro-Oncology, 2013

View PDFchevron_right

Bispecific antibodies targeting tumor-associated antigens and neutralizing complement regulators increase the efficacy of antibody-based immunotherapy in mice

Paolo Durigutto

Leukemia, 2014

View PDFchevron_right

A novel IgE antibody targeting the prostate-specific antigen as a potential prostate cancer therapy

Gustavo Helguera

BMC Cancer, 2013

View PDFchevron_right

Abstract 1764: DOTA-conjugated antibodies for scintigraphic evaluation of new anti cancer treatments

Franck Denat

Cancer Research, 2011

View PDFchevron_right

Bispecific antibody derivatives with restricted binding functionalities that are activated by proteolytic processing

Ulrich Brinkmann

Protein Engineering Design and Selection, 2012

View PDFchevron_right

Immunotherapy: breakthrough in Cancer Treatment

Mrs. Reshmi Gopalakrishnan

2023

View PDFchevron_right

BiologyCancer ResearchClinical PracticeCgCEDrug DesignEnzymeEpidermal Growth FactorEpidermal Growth Factor ReceptorAntibodyChronic myeloid leukemiaBevacizumabBiochemistry and molecular biologyGrowth FactorCell SurvivalAntineoplastic AgentsChronic myelogenous leukemiaGrowth factor receptorgene amplification